Soleno Therapeutics (SLNO) Profit After Tax (2013 - 2026)
Soleno Therapeutics (SLNO) posted quarterly Profit After Tax of $31.4 million for Q1 2026, up 171.68% year-over-year from $11.5 million in Q1 2025, and down 27.72% quarter-over-quarter from $43.4 million in Q4 2025.
Soleno Therapeutics (SLNO) Profit After Tax (2013 - 2026) Analysis & Trends
Soleno Therapeutics (SLNO) has reported Profit After Tax for 14 consecutive years, with $31.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Profit After Tax rose 171.68% year-over-year to $31.4 million; the TTM figure through Mar 2026 stood at $96.1 million (up 148.57% YoY), while the FY2025 annual figure was $20.9 million, up 111.93% from the prior year.
- Profit After Tax retreated to $31.4 million in Q1 2026 per SLNO's latest filing, from $43.4 million in the prior quarter.
- Across five years, Profit After Tax topped out at $43.4 million in Q4 2025 and bottomed at -$76.6 million in Q3 2024.
- Historically, Profit After Tax has averaged -$11.0 million across 5 years, with a median of -$8.4 million in 2023.
- Annual changes were most pronounced in 2024 — Profit After Tax plunged 605.36% — and 2025, when it soared 178.05%.
- Soleno Therapeutics' Profit After Tax stood at -$5.5 million in 2022, then slumped by 105.91% to -$11.3 million in 2023, then sank by 392.4% to -$55.6 million in 2024, then jumped by 178.05% to $43.4 million in 2025, then slipped by 27.72% to $31.4 million in 2026.
- Business Quant data shows SLNO's Profit After Tax at $31.4 million in Q1 2026, $43.4 million in Q4 2025, and $26.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 472.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 237.01 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,087.27 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 164.49 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.62 Mn |
| 10 | Soleno Therapeutics | 2.74 Bn | 2.49 Bn | 93.41 Mn | 31.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.38 Mn |
| Dec 31, 2025 | 43.41 Mn |
| Sep 30, 2025 | 26.01 Mn |
| Jun 30, 2025 | -4.71 Mn |
| Mar 31, 2025 | -43.77 Mn |
| Dec 31, 2024 | -55.62 Mn |
| Sep 30, 2024 | -76.62 Mn |
| Jun 30, 2024 | -21.85 Mn |
| Mar 31, 2024 | -21.40 Mn |
| Dec 31, 2023 | -11.30 Mn |
| Sep 30, 2023 | -10.86 Mn |
| Jun 30, 2023 | -8.48 Mn |
| Mar 31, 2023 | -8.36 Mn |
| Dec 31, 2022 | -5.49 Mn |
| Sep 30, 2022 | -6.13 Mn |
| Jun 30, 2022 | -6.73 Mn |
| Mar 31, 2022 | -5.72 Mn |
| Dec 31, 2021 | -2.83 Mn |
| Sep 30, 2021 | -8.14 Mn |
| Jun 30, 2021 | -10.99 Mn |